ClinicalTrials.Veeva

Menu

A Study to Evaluate the Safety and Effectiveness of Mirodenafil in Korean Patients With Erectile Dysfunction

Janssen (J&J Innovative Medicine) logo

Janssen (J&J Innovative Medicine)

Status

Terminated

Conditions

Erectile Dysfunction

Treatments

Drug: No intervention

Study type

Observational

Funder types

Industry

Identifiers

NCT01802359
MIRODENEDY4002 (Other Identifier)
MIR-KOR-PMS (Other Identifier)
CR100836

Details and patient eligibility

About

The purpose of this study is to evaluate the safety and effectiveness of mirodenafil in participants with erectile dysfunction.

Full description

This is a non randomized (the study medication is not assigned by chance), open-label (all participants and study staff know the identity of the treatment), multi-center, prospective (looking forward using observations collected following participant enrollment), and non-comparative study in which participants with erectile dysfunction will be observed to evaluate the safety and effectiveness of mirodenafil for 12 weeks. Safety evaluations will include assessment of adverse events, and record of concomitant medications. The study will be conducted in Korea.

Enrollment

379 patients

Sex

Male

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Participants diagnosed with erectile dysfunction
  • Participants prescribed mirodenafil on demand

Exclusion criteria

  • Participants who have administered mirodenafil for other than an approved indication

Trial design

379 participants in 1 patient group

Mirodenafil
Treatment:
Drug: No intervention

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems